InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Cash from Investing Activities (2016 - 2026)

InflaRx (IFRX) posted Cash from Investing Activities of $7.2 million for Q1 2026, down 21.65% sequentially from $9.2 million in Q4 2025, and down 61.3% YoY from $18.6 million in Q1 2025.

InflaRx (IFRX) Cash from Investing Activities (2016 - 2026) Analysis & Trends

InflaRx has reported Cash from Investing Activities for 11 years, with the latest figure at $7.2 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 61.3% year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.8 million (down 118.98% YoY) and the FY2025 annual result came in at $3.7 million, down 93.56% from the prior year.
  • Cash from Investing Activities slipped to $7.2 million in Q1 2026 per IFRX's latest filing, from $9.2 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $29.7 million in Q1 2022 and troughed at -$28.2 million in Q2 2025.
  • A 5-year average of $4.1 million and a median of $5.0 million in 2022 frame the typical range for Cash from Investing Activities.
  • The widest YoY moves for Cash from Investing Activities: up 2447.57% in 2022, down 1281.91% in 2022.
  • Over 5 years, Cash from Investing Activities stood at $1.8 million in 2022, then soared by 64.91% to $3.0 million in 2023, then plunged by 31.24% to $2.1 million in 2024, then soared by 338.76% to $9.2 million in 2025, then decreased by 21.65% to $7.2 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $7.2 million, $9.2 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn 14.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.19 Mn
Mar 31, 2026 7.19 Mn
Dec 31, 2025 9.17 Mn
Dec 31, 2025 9.17 Mn
Sep 30, 2025 3.04 Mn
Sep 30, 2025 3.04 Mn
Jun 30, 2025 -28.19 Mn
Jun 30, 2025 -28.19 Mn
Mar 31, 2025 18.57 Mn
Mar 31, 2025 18.57 Mn
Dec 31, 2024 2.09 Mn
Dec 31, 2024 2.09 Mn
Sep 30, 2024 19.19 Mn
Sep 30, 2024 19.19 Mn
Jun 30, 2024 6.45 Mn
Jun 30, 2024 6.45 Mn
Mar 31, 2024 29.27 Mn
Mar 31, 2024 29.27 Mn
Dec 31, 2023 3.04 Mn
Dec 31, 2023 3.04 Mn